Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT06102655

Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency Based on Metabolomics (JJGS and POI)

Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency

Sponsor: Shi Yun

Conditions Clinical Syndrome Mechanism Metabolomics Premature Ovarian Insufficiency Traditional Chinese Medicine

Interventions Jiajian Guishen Formulation

Updated 6 times since 2023 Last updated: Dec 4, 2024 Started: Jul 24, 2023 Primary completion: Jul 20, 2024 Completion: Jul 20, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Clinical Syndrome and Mechanism, this trial is completed. The trial is conducted by Shi Yun and has accumulated 6 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Jan 2025 — Present [monthly]

Completed EARLY_PHASE1
Oct 2024 — Jan 2025 [monthly]

Completed EARLY_PHASE1

Status: Recruiting → Completed
Sep 2024 — Oct 2024 [monthly]

Recruiting EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Recruiting EARLY_PHASE1
May 2024 — Jul 2024 [monthly]

Recruiting EARLY_PHASE1

▶ Show 1 earlier version

Nov 2023 — May 2024 [monthly]

Recruiting EARLY_PHASE1

First recorded

Jul 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shi Yun

Data source: Dongzhimen Hospital, Beijing

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China